companies / ultromics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 55,000,00055.0M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | Oxford, GB | |
| industry | unknown | |
| stage | series-b+ |
Ultromics builds AI diagnostic tools that analyze routine echocardiograms to detect cardiac conditions like heart failure and amyloidosis. It serves hospitals, clinics, and payers, partnering with Mayo Clinic and Northwestern Medicine. Its edge is FDA-cleared software that returns automated reports in about 20 minutes with no hardware install.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-07-31 | series-c | 55,000,00055.0M | null | ○ |
Cloudflare, Terminus, Linkedin Ads, Linkedin Insight Tag, YouTube, Google Analytics, Google Tag Manager, DoubleClick Floodlight, HubSpot CMS Hub, Cloudflare Bot Management, Cookie Script, web-vitals
| fact | status | src |
|---|---|---|
| Series C, $55.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |